These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 36258004
1. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report. Li J, Liu F, Liu X, Hu Y, Liu Z, Shen Y, Wan J. J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004 [Abstract] [Full Text] [Related]
2. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas. Kato I, Iribe Y, Nagashima Y, Kuroda N, Tanaka R, Nakatani Y, Hasumi H, Yao M, Furuya M. Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015 [Abstract] [Full Text] [Related]
3. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome. Hasumi H, Baba M, Hasumi Y, Furuya M, Yao M. Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100 [Abstract] [Full Text] [Related]
4. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome. Iribe Y, Kuroda N, Nagashima Y, Yao M, Tanaka R, Gotoda H, Kawakami F, Imamura Y, Nakamura Y, Ando M, Araki A, Matsushima J, Nakatani Y, Furuya M. Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876 [Abstract] [Full Text] [Related]
5. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome. Furuya M, Hasumi H, Baba M, Tanaka R, Iribe Y, Onishi T, Nagashima Y, Nakatani Y, Isono Y, Yao M. Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910 [Abstract] [Full Text] [Related]
6. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome. Furuya M, Yao M, Tanaka R, Nagashima Y, Kuroda N, Hasumi H, Baba M, Matsushima J, Nomura F, Nakatani Y. Clin Genet; 2016 Nov; 90(5):403-412. PubMed ID: 27220747 [Abstract] [Full Text] [Related]
7. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome. Furuya M, Hong SB, Tanaka R, Kuroda N, Nagashima Y, Nagahama K, Suyama T, Yao M, Nakatani Y. Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584 [Abstract] [Full Text] [Related]
8. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas. Näf E, Laubscher D, Hopfer H, Streit M, Matyas G. Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594 [Abstract] [Full Text] [Related]
9. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Petersson F, Gatalica Z, Grossmann P, Perez Montiel MD, Alvarado Cabrero I, Bulimbasic S, Swatek A, Straka L, Tichy T, Hora M, Kuroda N, Legendre B, Michal M, Hes O. Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772 [Abstract] [Full Text] [Related]
11. [DIAGNOSIS OF GENETIC VARIANT CARRIERS IN A PATIENT WITH ASYMPTOMATIC BIRT-HOGG-DUBÉ SYNDROME: A CASE REPORT]. Watari S, Ichikawa T, Hirasawa A, Shiraishi H, Tokunaga M, Kubota R, Kusumi N, Tsushima T, Shinno Y, Furuya M. Nihon Hinyokika Gakkai Zasshi; 2023 Apr; 114(2):61-65. PubMed ID: 38644188 [Abstract] [Full Text] [Related]
12. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. Houweling AC, Gijezen LM, Jonker MA, van Doorn MB, Oldenburg RA, van Spaendonck-Zwarts KY, Leter EM, van Os TA, van Grieken NC, Jaspars EH, de Jong MM, Bongers EM, Johannesma PC, Postmus PE, van Moorselaar RJ, van Waesberghe JH, Starink TM, van Steensel MA, Gille JJ, Menko FH. Br J Cancer; 2011 Dec 06; 105(12):1912-9. PubMed ID: 22146830 [Abstract] [Full Text] [Related]
13. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic. Enomoto Y, Namba Y, Hoshika Y, Komemushi Y, Mitani K, Kume H, Kobayashi E, Miyama Y, Homma Y, Ushiku T, Seyama K. Eur J Med Genet; 2020 Apr 06; 63(4):103820. PubMed ID: 31778855 [Abstract] [Full Text] [Related]
14. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review. Furuya M, Nakatani Y. Pathol Int; 2019 Jan 06; 69(1):1-12. PubMed ID: 30632664 [Abstract] [Full Text] [Related]
15. [Birt-Hogg-Dubé syndrome: an update]. López V, Jordá E, Monteagudo C. Actas Dermosifiliogr; 2012 Apr 06; 103(3):198-206. PubMed ID: 21937013 [Abstract] [Full Text] [Related]
16. New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome. Kennedy JC, Khabibullin D, Boku Y, Shi W, Henske EP. Semin Respir Crit Care Med; 2020 Apr 06; 41(2):247-255. PubMed ID: 32279295 [Abstract] [Full Text] [Related]
17. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer. Dong L, Gao M, Hao WJ, Zheng XQ, Li YG, Li XL, Yu Y. Medicine (Baltimore); 2016 May 06; 95(22):e3695. PubMed ID: 27258496 [Abstract] [Full Text] [Related]
20. Genome-Wide Uniparental Disomy and Copy Number Variations in Renal Cell Carcinomas Associated with Birt-Hogg-Dubé Syndrome. Iribe Y, Yao M, Tanaka R, Kuroda N, Nagashima Y, Nakatani Y, Furuya M. Am J Pathol; 2016 Feb 06; 186(2):337-46. PubMed ID: 26776076 [Abstract] [Full Text] [Related] Page: [Next] [New Search]